beyondMD

1. 3. The process page describes a scheduled private telehealth consultation and separately says a live or video visit may depend on the patient’s state. This supports a live consultation pathway without establishing an independent asynchronous prescribing option. Generic all-50-state footer language conflicts with the process page’s “most states” wording; program eligibility remains state- and prescription-dependent. No dispensing pharmacy is named in the program or process pages.
2. 4. The plain semaglutide page lists consultation among program benefits but does not establish a separate consultation charge. The B12 variant explicitly bills consultation and shipping separately; that variant-only charge is not applied to the plain offer. https://beyondmd.com/all-programs/compounded-semaglutide-injections/
3. 5. Zepbound is an actual consultation-and-prescribing program, subject to clinical approval. The $129 starting figure identifies the consultation program; the drug price, dose, supply interval and full invoice are not disclosed. The page explicitly describes premeasured single-dose vials. https://beyondmd.com/all-programs/zepbound/
4. 6. Wegovy is an actual consultation-and-prescribing program, subject to clinical approval. The $129 starting figure identifies the consultation program; the drug price, dose, supply interval and full invoice are not disclosed. The page describes weekly subcutaneous injections without identifying a pen or vial. https://beyondmd.com/all-programs/wegovy/
5. 7. The oral semaglutide heading advertises $149, while the body says pricing starts at $125 and the FAQ describes approximately $125 per month. These conflicting advertisements do not establish one payable invoice. Consultation is required and shipping costs extra. The page describes a daily swallowed tablet; it does not identify a named brand product. https://beyondmd.com/all-programs/oral-semaglutide/
6. 8. A provider consultation is required, but the source does not establish whether it carries a separate charge or is included in the program. Separately stated shipping fees do not establish a consultation fee. https://beyondmd.com/all-programs/oral-semaglutide/
7. 9. The oral tirzepatide heading advertises $249, while its description says starting at $199.99. No single payment or billing period is established. Consultation is required and shipping costs extra. The current text identifies oral administration without establishing a tablet, capsule or sublingual preparation; the earlier tablet classification is not substantiated by this rereading. https://beyondmd.com/all-programs/oral-tirzepatide/
8. 10. A provider consultation is required, but the source does not establish whether it carries a separate charge or is included in the program. Separately stated shipping fees do not establish a consultation fee. https://beyondmd.com/all-programs/oral-tirzepatide/
9. 11. The current compounded tirzepatide injection offer starts at $199 without a stated payment or supply interval. A conflicting $209 HTML title is not a verified payable offer. The product text establishes injection without confirming the actual container; it does not prove a vial. Free membership is advertised, but the complete medication, consultation and shipping invoice is not established. https://beyondmd.com/all-programs/compounded-tirzepatide-injections/

October 2026

1. 12. The product page states a starting price and free membership, but does not establish the payment interval or initial invoice. Confirm the medication supply, consultation charges and shipping before ordering.
2. 13. The advertised $129 figure identifies a consultation program. It does not establish the medication cost, payment interval or full initial invoice. Confirm drug charges and any additional costs before enrolling.
3. 14. The catalog advertises oral semaglutide starting at $149, while the older product-page excerpt says $125. The product page could not be reread in this pass. These are unresolved offers, not a verified price change or a confirmed monthly bill.
4. 15. The oral tirzepatide page shows two starting prices, $249 in its heading and $199.99 in its description. It does not establish one payment amount or billing period. Consultation is required and shipping costs extra; confirm the complete invoice before ordering.

September 2026

1. 16. The 'membership' here is free ($0) and is presented alongside each program's price, not a separate paid fee excluding medication — included for completeness only. Contradiction found: the compounded-tirzepatide-injections page's own HTML <title> reads 'Compounded Tirzepatide Injections | Starts at $209' while the visible body text on the same page says 'Starting at $199' twice — the $209 figure never appears in visible body text, only in the title tag. Individual Zepbound/Wegovy product pages could not be reached (guessed URL slugs 404'd); their prices are sourced only from the category page, which truncates each product's description with '...'. No synchronous/asynchronous prescriber-visit language was found on the pages checked.